What Clinical Trials Reveal About Orlistat vs Wegovy
Orlistat vs Wegovy Weight Loss Results: Clinical Trial Evidence
The most striking difference between orlistat and Wegovy lies in their clinical trial outcomes and mechanisms of action. Orlistat (Xenical/Alli) works by blocking approximately 30% of dietary fat absorption in the intestines, typically supporting 5-clinically studied weight loss when combined with a low-fat diet. In contrast, Wegovy's STEP trials demonstrated significantly different results—patients taking semaglutide alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks (Wilding et al., NEJM, 2021).
When comparing orlistat vs Wegovy for UK patients, it's essential to understand that these medications work through entirely different pathways. Orlistat requires strict dietary compliance to avoid uncomfortable gastrointestinal side effects, whilst Wegovy mimics GLP-1 hormones to naturally reduce appetite and promote satiety. The STEP 3 trial showed even higher results of around clinically studied weight loss when Wegovy was combined with intensive behavioural therapy, highlighting the importance of comprehensive weight management support.
Orlistat vs Wegovy Pricing: UK Prescription Costs Compared
Understanding the cost implications of orlistat vs Wegovy helps inform your weight management investment. Orlistat typically costs £30-50 per month from UK pharmacies, requiring three capsules daily with meals. Wegovy pricing at EverydayMeds starts from £79.99 for the 0.25mg starter dose, escalating to £209.99 for the 2.4mg maintenance dose—but remember, this represents once-weekly dosing versus orlistat's 84 capsules monthly.
Our bundle options make Wegovy more accessible for sustained treatment. The Intro Duo (0.25mg & 0.5mg) costs £169.99 with code FIRST40, covering your first two months of dose escalation. For patients reaching maintenance therapy, our Ultimate Stability Trio provides three months of 2.4mg supply for £649.99. When evaluating orlistat vs Wegovy costs, consider the convenience factor—Wegovy's weekly injection eliminates the daily pill burden and dietary fat restrictions that orlistat requires.
STEP Trial Results: Wegovy's Evidence Base in Orlistat vs Wegovy Comparisons
The robust clinical evidence supporting Wegovy sets it apart in any orlistat vs Wegovy evaluation. STEP 1 enrolled 1,961 adults with obesity, demonstrating that patients taking Wegovy alongside reduced-calorie diet and increased physical activity achieved approximately clinically studied weight loss versus 2.4% with placebo at 68 weeks. STEP 5 extended this evidence, showing sustained weight loss of around 15.2% at two years, addressing long-term effectiveness concerns.
Additional STEP trials strengthen the orlistat vs Wegovy evidence comparison. STEP 2 specifically studied patients with type 2 diabetes, showing approximately clinically studied weight loss, whilst the recent SELECT cardiovascular outcomes trial demonstrated a 20% reduction in major cardiovascular events. This cardiovascular benefit hasn't been established for orlistat, making Wegovy particularly relevant for patients with weight-related comorbidities requiring comprehensive risk management.
How Wegovy Works Differently to Orlistat in Weight Management
The fundamental difference in orlistat vs Wegovy mechanisms explains their varying clinical outcomes and patient experiences. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics glucagon-like peptide-1—a natural hormone released after eating that signals fullness to the brain. This mechanism reduces appetite centrally, helping patients feel satisfied with smaller portions without the conscious dietary restriction that orlistat demands. Wegovy also slows gastric emptying, prolonging satiety and reducing food cravings between meals. Additionally, semaglutide may influence reward pathways in the brain associated with food preferences, potentially reducing cravings for high-calorie foods. The once-weekly FlexTouch pen delivery system ensures consistent medication levels, unlike orlistat's three-times-daily dosing that depends on meal timing and fat content.
Ordering Wegovy vs Orlistat: EverydayMeds Process
Accessing genuine Wegovy through our GPhC-registered pharmacy (#9012878) involves a streamlined three-minute online clinical assessment covering your weight management history, current medications, and treatment goals. Our qualified prescribers review your assessment within three working days (or 24 hours with express service), ensuring Wegovy is clinically appropriate versus orlistat or other options. Once approved, we dispatch your prescription-only medicine via next-day delivery using cold-chain transportation to maintain the 2-8°C storage requirement. This temperature-controlled logistics distinguish legitimate UK supply from overseas sources that may compromise medication integrity. Our process includes clear injection guidance, dose escalation schedules, and ongoing support—comprehensive care that reflects Wegovy's sophisticated mechanism compared to orlistat's simpler fat-blocking action.
Practical Differences: Orlistat vs Wegovy Daily Management
The practical aspects of orlistat vs Wegovy significantly impact treatment adherence and lifestyle integration. Orlistat requires three capsules daily with main meals, necessitating careful timing and a low-fat diet to prevent uncomfortable gastrointestinal effects like oily stools or fatty food malabsorption. Wegovy's weekly FlexTouch pen eliminates daily pill-taking, requiring only once-weekly subcutaneous injection at any time of day, with or without food. Wegovy offers superior travel convenience—the pen remains stable at room temperature below 30°C for up to six weeks once removed from refrigerated storage, whilst orlistat capsules need protection from moisture but don't require refrigeration. The dose escalation protocol (0.25mg→0.5mg→1mg→1.7mg→2.4mg over 16 weeks) is built into Wegovy's prescribing to optimise tolerability, whereas orlistat maintains the same 120mg three-times-daily dose throughout treatment.
UK Prescribing Criteria: Orlistat vs Wegovy Eligibility
MHRA licensing determines when prescribers can recommend orlistat vs Wegovy for UK patients, with both requiring BMI ≥30 or BMI ≥27 with weight-related comorbidities. However, NICE guidance TA875 specifically recommends Wegovy with specialist weight management support, reflecting its enhanced efficacy profile compared to orlistat's broader availability. Orlistat can be prescribed by any healthcare professional and is available over-the-counter in lower doses, making it more accessible but potentially less supervised.
The prescriber assessment for orlistat vs Wegovy considers different contraindications and monitoring requirements. Wegovy requires screening for personal or family history of thyroid cancer, previous pancreatitis, and diabetic retinopathy—reflecting its GLP-1 mechanism's broader physiological effects. Orlistat's main contraindications involve fat malabsorption conditions and chronic kidney disease. Both medications must be prescribed alongside reduced-calorie diet and increased physical activity, but Wegovy's appetite-suppressing mechanism often makes dietary compliance more achievable than orlistat's restrictive fat intake requirements.
Making Your Orlistat vs Wegovy Decision with EverydayMeds
Choosing between orlistat vs Wegovy represents a significant weight management decision that deserves expert guidance and reliable supply. Our clinical team understands that each patient's circumstances—from BMI and comorbidities to lifestyle and preferences—influence treatment suitability. With codes FIRST40 for new customers or DOSE25 for returning patients applied at checkout, you access genuine Wegovy from £79.99 with complete prescriber oversight and pharmaceutical-grade cold-chain delivery. The evidence strongly favours Wegovy's superior efficacy in clinical trials, but individual factors determine optimal treatment selection. Our GPhC-registered service (#9012878) ensures you receive authentic prescription-only medicine with proper clinical governance, unlike unregulated online sources that may compromise your safety and treatment outcomes. Visit https://everydaymeds.co.uk/collections/wegovy to begin your clinical assessment and discuss whether Wegovy represents the right choice for your weight management journey.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
